SO-10 An open-label, multi-centre, phase Ib/II study of PI3Kβ selective inhibitor GSK2636771 administered in combination with paclitaxel in patients with advanced gastric cancer having alterations in PI3K/Akt pathway
Title:
SO-10 An open-label, multi-centre, phase Ib/II study of PI3Kβ selective inhibitor GSK2636771 administered in combination with paclitaxel in patients with advanced gastric cancer having alterations in PI3K/Akt pathway
Author:
Jung, M. Kim, C. Kim, H. Lee, C. Lee, H. Bae, W. Jeung, H. Zang, D. Park, S. Hwang, I. Kim, H. Rha, S. Chung, H.